CRISPR 2.0: new wave gene editors heads for clinical trials-see epigenome editing | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  177116 of 178390  at  12/7/2023 4:44:27 PM  by

Watsonncrick

The following message was updated on 12/7/2023 4:45:54 PM.

Re:CRISPR 2.0: new wave gene editors heads for clinical trials-see epigenome editing

https://www.nature.com/articles/d41586-023-03797-7

Technologies targeting the epigenome have not moved as quickly as base editing. In part, that’s because scientists assumed that epigenome edits would be erased during cell division, says Derek Jantz, chief scientific officer of Tune Therapeutics in Durham, North Carolina. “That’s a common misconception,” he says. “But epigenetics is very long-lasting.”


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 5  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
177119 Re:CRISPR 2.0: new wave gene editors heads for clinical trials-see epigenome editing dachmeister4u 6 12/8/2023 10:11:38 AM




Financial Market Data provided by
.
Loading...